223 related articles for article (PubMed ID: 19929417)
41. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
Lee YH; Park HI; Chang WS; Choi JS
Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
[TBL] [Abstract][Full Text] [Related]
42. Isofraxidin, a potent reactive oxygen species (ROS) scavenger, protects human leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in p53-independent manner.
Li P; Zhao QL; Wu LH; Jawaid P; Jiao YF; Kadowaki M; Kondo T
Apoptosis; 2014 Jun; 19(6):1043-53. PubMed ID: 24692054
[TBL] [Abstract][Full Text] [Related]
43. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis.
Dhanasekaran A; Kotamraju S; Kalivendi SV; Matsunaga T; Shang T; Keszler A; Joseph J; Kalyanaraman B
J Biol Chem; 2004 Sep; 279(36):37575-87. PubMed ID: 15220329
[TBL] [Abstract][Full Text] [Related]
44. Core-shell hybrid upconversion nanoparticles carrying stable nitroxide radicals as potential multifunctional nanoprobes for upconversion luminescence and magnetic resonance dual-modality imaging.
Chen C; Kang N; Xu T; Wang D; Ren L; Guo X
Nanoscale; 2015 Mar; 7(12):5249-61. PubMed ID: 25716884
[TBL] [Abstract][Full Text] [Related]
45. Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted anti-oxidants.
Fink MP; Macias CA; Xiao J; Tyurina YY; Jiang J; Belikova N; Delude RL; Greenberger JS; Kagan VE; Wipf P
Biochem Pharmacol; 2007 Sep; 74(6):801-9. PubMed ID: 17601494
[TBL] [Abstract][Full Text] [Related]
46. Knockout of mitochondrial voltage-dependent anion channel type 3 increases reactive oxygen species (ROS) levels and alters renal sodium transport.
Zou L; Linck V; Zhai YJ; Galarza-Paez L; Li L; Yue Q; Al-Khalili O; Bao HF; Ma HP; Thai TL; Jiao J; Eaton DC
J Biol Chem; 2018 Feb; 293(5):1666-1675. PubMed ID: 29180450
[TBL] [Abstract][Full Text] [Related]
47. Metabolism in rat liver microsomes of the nitroxide spin probe tempol.
Iannone A; Bini A; Swartz HM; Tomasi A; Vannini V
Biochem Pharmacol; 1989 Aug; 38(16):2581-6. PubMed ID: 2764982
[TBL] [Abstract][Full Text] [Related]
48. Development of novel nitroxyl radicals for controlling reactivity with ascorbic acid.
Kinoshita Y; Yamada K; Yamasaki T; Sadasue H; Sakai K; Utsumi H
Free Radic Res; 2009 Jun; 43(6):565-71. PubMed ID: 19384748
[TBL] [Abstract][Full Text] [Related]
49. Mitochondrial accumulation of a lipophilic cation conjugated to an ionisable group depends on membrane potential, pH gradient and pK(a): implications for the design of mitochondrial probes and therapies.
Finichiu PG; James AM; Larsen L; Smith RA; Murphy MP
J Bioenerg Biomembr; 2013 Feb; 45(1-2):165-73. PubMed ID: 23180142
[TBL] [Abstract][Full Text] [Related]
50. Modulation of oxidative damage by nitroxide free radicals.
Dragutan I; Mehlhorn RJ
Free Radic Res; 2007 Mar; 41(3):303-15. PubMed ID: 17364959
[TBL] [Abstract][Full Text] [Related]
51. On the distinction between nitroxyl and nitric oxide using nitronyl nitroxides.
Samuni U; Samuni Y; Goldstein S
J Am Chem Soc; 2010 Jun; 132(24):8428-32. PubMed ID: 20504018
[TBL] [Abstract][Full Text] [Related]
52. Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants.
Fink MP; Macias CA; Xiao J; Tyurina YY; Delude RL; Greenberger JS; Kagan VE; Wipf P
Crit Care Med; 2007 Sep; 35(9 Suppl):S461-7. PubMed ID: 17713394
[TBL] [Abstract][Full Text] [Related]
53. Factors influencing nitroxide reduction and cytotoxicity in vitro.
Samuni Y; Gamson J; Samuni A; Yamada K; Russo A; Krishna MC; Mitchell JB
Antioxid Redox Signal; 2004 Jun; 6(3):587-95. PubMed ID: 15130285
[TBL] [Abstract][Full Text] [Related]
54. To be a radical or not to be one? The fate of the stable nitroxide radical TEMPO [(2,2,6,6-Tetramethylpiperidin-1-yl)oxyl] undergoing plasma polymerization into thin-film coatings.
Michl TD; Tran DTT; Böttle K; Kuckling HF; Zhalgasbaikyzy A; Ivanovská B; Cavallaro AA; Araque Toledo MA; Sherman PJ; Al-Bataineh SA; Vasilev K
Biointerphases; 2020 Jun; 15(3):031015. PubMed ID: 32590900
[TBL] [Abstract][Full Text] [Related]
55. The relationship between structure and antioxidative activity of piperidine nitroxides.
Li WG; Zhang XY; Wu YJ; Gao MT; Zheng RL
J Pharm Pharmacol; 2006 Jul; 58(7):941-9. PubMed ID: 16805954
[TBL] [Abstract][Full Text] [Related]
56. The mitochondria-targeted nitroxide JP4-039 augments potentially lethal irradiation damage repair.
Rajagopalan MS; Gupta K; Epperly MW; Franicola D; Zhang X; Wang H; Zhao H; Tyurin VA; Pierce JG; Kagan VE; Wipf P; Kanai AJ; Greenberger JS
In Vivo; 2009; 23(5):717-26. PubMed ID: 19779106
[TBL] [Abstract][Full Text] [Related]
57. Scavenging with TEMPO* to identify peptide- and protein-based radicals by mass spectrometry: advantages of spin scavenging over spin trapping.
Wright PJ; English AM
J Am Chem Soc; 2003 Jul; 125(28):8655-65. PubMed ID: 12848573
[TBL] [Abstract][Full Text] [Related]
58. Mitochondria-Targeted Antioxidant Mito-Tempo Protects Against Aldosterone-Induced Renal Injury In Vivo.
Ding W; Liu T; Bi X; Zhang Z
Cell Physiol Biochem; 2017; 44(2):741-750. PubMed ID: 29169180
[TBL] [Abstract][Full Text] [Related]
59. Dihydroxy-Substituted Coumarins as Fluorescent Probes for Nanomolar-Level Detection of the 4-Amino-TEMPO Spin Label.
Żamojć K; Zdrowowicz M; Hać A; Witwicki M; Rudnicki-Velasquez PB; Wyrzykowski D; Wiczk W; Chmurzyński L
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382639
[TBL] [Abstract][Full Text] [Related]
60. Kinetics and mechanism of hydroxyl radical and OH-adduct radical reactions with nitroxides and with their hydroxylamines.
Samuni A; Goldstein S; Russo A; Mitchell JB; Krishna MC; Neta P
J Am Chem Soc; 2002 Jul; 124(29):8719-24. PubMed ID: 12121116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
